Loading clinical trials...
Loading clinical trials...
The purpose of this phase II study is to evaluate an investigational monoclonal antibody for the treatment of glucocorticoid-refractory Graft Versus Host Disease (GVHD). Patients diagnosed with GVHD w...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Fred Hutchinson Cancer Center
Collaborators
NCT01940796 · Graft-vs-Host Disease, GVHD
NCT02409134 · Quality of Life, Graft-vs-Host Disease
NCT00548717 · Graft-vs-Host Disease
NCT00189748 · Bone Marrow Transplantation, Graft Versus Host Disease, and more
City of Hope National Medical Center
Duarte, California
Stanford University Medical Center
Stanford, California
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions